home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Metabolic Diseases  
  March 04, 2002

Pharmacology and Toxicology

 
     
  Park Hyatt at the Bellevue Hotel, Philadelphia
May 6-7, 2002


ORGANIZED INTO THREE SECTIONS:

- DISCOVERY & DRUG TARGET IDENTIFICATION
- LEAD STRUCTURE IDENTIFICATION & CHARACTERIZATION
- PRE-CLINICAL/CLINICAL DEVELOPMENT

FEATURING:

- Type 2 Diabetes Insulin Sensitizer
- Leptin
- Next Generation Diabetes Drug Targets
- Thermogenesis
- Antidiabetic Properties of GSK3 Inhibitors
- PPAR-Gamma
- Antisense Use in Diabetes
- Transcription Factors
- Insulin Resistance
- Combination Therapy in Obesity
- Mitochodrial Approaches
- Functional Genomics

 
 
Organized by: Strategic Research Institute
Invited Speakers: HIGHLIGHTS INCLUDE:

Signaling Mechanism that Regulate Expression of UCP1
Sheila Collins, Ph.D., Duke University Medical Center

Elucidation of Signaling Pathways and Transcription
Stephen R. Farmer, M.D., Boston University School of Medicine

Leptin as a Human Therapeutic
Alex DePaoli, M.D., Amgen

Inhibitors at New Allosteric Sites for Glycogen Phosphorylase & Fructose-1,6-Bisphosphatase
Judith L. Treadway, Ph.D., Pfizer Global R & D - Groton Laboratories


PRESENTATIONS BY:

AGOURON PHARMACEUTICALS
AMGEN
BOSTON UNIVERSITY SCHOOL OF MEDICINE
CHIRON CORPORATION
DEVELOGEN AG
DIGITAL GENE TECHNOLOGIES
DUKE UNIVERSITY
F. HOFFMAN-LA ROCHE
GENEFORMATICS
ISIS PHARMACEUTICALS
LEXICON GENETICS
MERCK RESEARCH LABS
METABOLEX
MITOKOR
NOVO NORDISK
PALATIN TECHNOLOGIES
PFIZER GLOBAL R & D - GROTON LABS
PFIZER GLOBAL R & D - LA JOLLA LABS
REGENERON PHARMACETICALS

 
Deadline for Abstracts: none
 
Registration: www.srinstitute.com/cs208
(212) 967-0095
E-mail: ckahan-radhuber@srinstitute.com
 
  Posted by:   Cheryl Kahan-Radhuber  
Host: 12.3.58.15
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2002 HUM-MOLGEN. All rights reserved. Liability and Copyright.